Evrys Bio awarded Phase II SBIR grant from the NIH National Institute for Allergy and Infectious Disease titled, “A Single Antiviral to Treat Multiple Opportunistic Infections” (5R44AI11407902). Details are HERE
Sitemap
Evrys Bio
3805 Old Easton Road
Doylestown, PA 18902
View the FCOI Policy pertaining to federally funded projects

Leave a Reply
Want to join the discussion?Feel free to contribute!